M Roselli Selected Research

M Roselli Research Topics

Disease

15	Neoplasms (Cancer) 11/2020 - 05/2000
7	Neoplasm Metastasis (Metastasis) 09/2014 - 07/2001
5	Breast Neoplasms (Breast Cancer) 12/2012 - 01/2000
4	Colorectal Neoplasms (Colorectal Cancer) 01/2009 - 03/2001
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2007 - 08/2001
3	Venous Thromboembolism 12/2014 - 05/2011
2	Adenocarcinoma 01/2021 - 01/2002
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2003
2	Inflammation (Inflammations) 01/2015 - 10/2009
2	Lung Neoplasms (Lung Cancer) 09/2014 - 01/2002
1	COVID-19 08/2022
1	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2022
1	Anemia 03/2017
1	Ischemia 01/2015
1	Hyperglycemia 01/2015
1	Febrile Neutropenia 01/2014
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2013
1	Abdominal Obesity 01/2012
1	Obesity 01/2012
1	Carcinogenesis 01/2012
1	Diarrhea 08/2011
1	Infections 03/2007
1	Ulcer 11/2005
1	Chronic Obstructive Pulmonary Disease (COPD) 06/2004
1	Margins of Excision 05/2002
1	Melanoma (Melanoma, Malignant) 05/2002
1	Breast Diseases (Breast Disease) 07/2001
1	Colonic Polyps 03/2001
1	Carcinoma (Carcinomatosis) 03/2001
1	Colonic Neoplasms (Colon Cancer) 03/2001

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 09/2014 - 03/2001
3	Insulin (Novolin)FDA Link 01/2015 - 01/2012
3	Fluorouracil (Carac)FDA LinkGeneric 10/2013 - 06/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2017 - 06/2005
2	Biological ProductsIBA 03/2017 - 01/2000
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2013 - 06/2005
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2011 - 11/2005
2	Thrombin FDA Link 05/2011 - 06/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 06/2004
2	Carcinoembryonic AntigenIBA 08/2001 - 03/2001
2	Tumor Biomarkers (Tumor Markers)IBA 07/2001 - 03/2001
1	Immune Checkpoint InhibitorsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015
1	GlucocorticoidsIBA 01/2015
1	LipidsIBA 12/2014
1	HDL CholesterolIBA 12/2014
1	CoagulantsIBA 09/2014
1	Heparin (Liquaemin)FDA LinkGeneric 09/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2014
1	Platinum Compounds (Compounds, Platinum)IBA 10/2013
1	AdiponectinIBA 01/2012
1	LeptinIBA 01/2012
1	CytokinesIBA 01/2012
1	ResistinIBA 01/2012
1	Protein CIBA 05/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2009
1	HomocysteineIBA 10/2009
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2009
1	Bevacizumab (Avastin)FDA Link 01/2009
1	Antineoplastic Agents (Antineoplastics)IBA 01/2009
1	Plant ExtractsIBA 03/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2007
1	Gemcitabine FDA Link 02/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2007
1	Cisplatin (Platino)FDA LinkGeneric 02/2007
1	Vinorelbine (Navelbine)FDA LinkGeneric 02/2007
1	Leucovorin (Folinic Acid)FDA Link 06/2005
1	AntithrombinsIBA 06/2004
1	Interleukin-6 (Interleukin 6)IBA 06/2004
1	fibrin fragment D (D-dimer)IBA 06/2004
1	CA-72-4 antigenIBA 01/2003
1	Indicators and Reagents (Reagents)IBA 01/2003
1	Coloring Agents (Dyes)IBA 05/2002
1	P-SelectinIBA 01/2002
1	SelectinsIBA 01/2002
1	tissue polypeptide specific antigenIBA 07/2001
1	Messenger RNA (mRNA)IBA 03/2001
1	Proteins (Proteins, Gene)FDA Link 03/2001
1	GangliosidesIBA 05/2000

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 12/2014 - 07/2001
4	Therapeutics 09/2014 - 01/2000
1	Personal Protective Equipment 08/2022
1	Immunotherapy 11/2020
1	Continuity of Patient Care 05/2009
1	Lymph Node Excision (Lymph Node Dissection) 05/2002
1	Operative Surgical Procedures 05/2002
1	Adjuvant Chemotherapy 08/2001
1	Neoadjuvant Therapy 07/2001
1	Intralesional Injections 05/2001
1	Investigational Therapies (Experimental Therapy) 03/2001